<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01832818</url>
  </required_header>
  <id_info>
    <org_study_id>C01</org_study_id>
    <nct_id>NCT01832818</nct_id>
  </id_info>
  <brief_title>Post-Market Study Evaluating the Safety and Effectiveness of NuNec速 Cervical Arthroplasty System</brief_title>
  <official_title>A Prospective, Feasibility, Multi-Center Nonrandomized Clinical Trial Evaluating the Safety and Effectiveness of NuNec速 Cervical Arthroplasty System</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Pioneer Surgical Technology, Inc.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Pioneer Surgical Technology, Inc.</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The objective of this study is to evaluate long-term safety and effectiveness of the NuNec速
      Cervical Arthroplasty System in a small patient population. The NuNec device is currently CE
      marked and commercially available in Europe.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The NuNec速 feasibility study is a prospective, multi-centered, non-randomized clinical trial.
      Only patients who have been diagnosed with single level, C3 to C7, symptomatic cervical
      degenerative disc disease and have failed at least 6 weeks of conservative treatment or
      present signs of progression of spinal cord/nerve root compression with continued
      non-operative care will be enrolled.

      Patients will be evaluated preoperatively and postoperatively at discharge, 6 weeks, 3, 6, 12
      and 24 months.
    </textblock>
  </detailed_description>
  <overall_status>Terminated</overall_status>
  <why_stopped>
    This study has been terminated early due to slow enrolment.
  </why_stopped>
  <start_date>March 2012</start_date>
  <completion_date type="Actual">January 2016</completion_date>
  <primary_completion_date type="Actual">January 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Neck Disability Index (NDI) Score Improvement of at Least 15 Points</measure>
    <time_frame>At 24 months</time_frame>
    <description>The Neck Disability Index is a patient reported outcome measure for self-rated disability due to neck pain. Each of the 10 items is scored from 0 - 5. The maximum score is therefore 50. The obtained score can be multiplied by 2 to produce a percentage score. A higher score would indicate that the patient did not improve.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Visual Analog Scale (VAS) Improvement of 2.0 cm for Neck Pain</measure>
    <time_frame>At 24 months</time_frame>
    <description>The pain Visual Analog Scale is a uni-dimensional measure of pain intensity, represented by a 100 mm line, anchored by &quot;no pain&quot; (score of 0) and &quot;pain as bad as it could be&quot; or &quot;worst imaginable pain&quot; (score of 100 [100-mm scale]). A higher score would indicate that the patient had a worse outcome.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Serious Adverse Events Related to the Device</measure>
    <time_frame>Up to 24 months</time_frame>
    <description>The number of serious adverse events have been recorded</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Device Failures or Removals, Revisions, Re-operations</measure>
    <time_frame>Up to 24 months</time_frame>
    <description>The failures or re-operations or supplemental fixation at the treated level</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Patient Satisfaction</measure>
    <time_frame>At 24 months</time_frame>
    <description>As assessed on patient questionnaire.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Absence of Device Migration or Subsidence</measure>
    <time_frame>Up to 24 months</time_frame>
    <description>Absence of device migration &gt; 3mm; Absence of device subsidence &gt; 3mm</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">14</enrollment>
  <condition>Cervical Intervertebral Disc Degeneration</condition>
  <arm_group>
    <arm_group_label>NuNec Cervical Disc</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Each patient will be implanted with the NuNec Cervical Disc in a single level from C3 to C7. Postoperatively, patient evaluated at discharge, 6 weeks, 3, 6, 12 and 24 months.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>NuNec Cervical Disc</intervention_name>
    <description>Patients will be enrolled and implanted with the NuNec device at a single level C3 to C7.</description>
    <arm_group_label>NuNec Cervical Disc</arm_group_label>
    <other_name>NuNec Cervical Arthroplasty System</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  is at least 21 years of age and skeletally mature

          -  must have symptomatic degenerative disc disease at one level in the cervical spine, C3
             to C7, demonstrated by herniated disc and/or spondylosis;

          -  must have completed a minimum of six weeks of unsuccessful conservative, non-operative
             care or has the presence of progressive symptoms or signs of nerve root/spinal cord
             compression in the face of conservative treatment

          -  must score at least 15/50 (30%) on the Neck Disability Index

          -  is willing and able to follow the post-operative management program

          -  must understand and sign the informed consent document

        Exclusion Criteria:

          -  symptomatic cervical DDD at more than one level

          -  axial neck pain as the primary diagnosis without evidence of neural compression

          -  neck or arm pain of unknown etiology

          -  any significant anatomical consideration which would make the anterior cervical
             approach excessively risky or impossible

          -  severe spondylosis at the target level

          -  prior surgery at the target level

          -  fused level adjacent to the target level

          -  osteoporosis, osteopenia, osteomalacia, Paget's disease or metabolic bone disease

          -  active infection or surgical site infection

          -  is using any medication known to interfere with bone/soft tissue healing

          -  diabetes mellitus requiring daily insulin management

          -  any terminal, systemic, or autoimmune disease

          -  medical conditions or mental incompetence which may interfere with study requirements

          -  BMI &gt;40 or a weight more than 100 lbs over ideal body weight

          -  chemical dependency problem that may interfere with study requirements

          -  current smokers

          -  history of any invasive malignancy unless treated and in remission for at least two
             years

          -  documented allergies to metal or plastic

          -  currently pregnant, or interested in becoming pregnant during the study follow-up
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>21 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Tai Friesem, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Hospital of North Tees</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University Hospital of North Tees</name>
      <address>
        <city>Stockton-on-Tees</city>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United Kingdom</country>
  </location_countries>
  <removed_countries>
    <country>Germany</country>
  </removed_countries>
  <verification_date>October 2018</verification_date>
  <study_first_submitted>April 10, 2013</study_first_submitted>
  <study_first_submitted_qc>April 15, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 16, 2013</study_first_posted>
  <results_first_submitted>February 5, 2018</results_first_submitted>
  <results_first_submitted_qc>October 1, 2018</results_first_submitted_qc>
  <results_first_posted type="Actual">February 15, 2019</results_first_posted>
  <last_update_submitted>October 1, 2018</last_update_submitted>
  <last_update_submitted_qc>October 1, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">February 15, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Total Disc Replacement</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Intervertebral Disc Degeneration</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>NuNec Cervical Disc</title>
          <description>Each patient will be implanted with the NuNec Cervical Disc in a single level from C3 to C7. Postoperatively, patient evaluated at discharge, 6 weeks, 3, 6, 12 and 24 months.
NuNec Cervical Disc: Patients will be enrolled and implanted with the NuNec device at a single level C3 to C7.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="14"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="8"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="6"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Lost to Follow-up</title>
              <participants_list>
                <participants group_id="P1" count="6"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>NuNec Cervical Disc</title>
          <description>Each patient will be implanted with the NuNec Cervical Disc in a single level from C3 to C7. Postoperatively, patient evaluated at discharge, 6 weeks, 3, 6, 12 and 24 months.
NuNec Cervical Disc: Patients will be enrolled and implanted with the NuNec device at a single level C3 to C7.</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="14"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="44" spread="7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="9"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Neck Disability Index (NDI) Score Improvement of at Least 15 Points</title>
        <description>The Neck Disability Index is a patient reported outcome measure for self-rated disability due to neck pain. Each of the 10 items is scored from 0 - 5. The maximum score is therefore 50. The obtained score can be multiplied by 2 to produce a percentage score. A higher score would indicate that the patient did not improve.</description>
        <time_frame>At 24 months</time_frame>
        <group_list>
          <group group_id="O1">
            <title>NuNec Cervical Disc</title>
            <description>Each patient will be implanted with the NuNec Cervical Disc in a single level from C3 to C7. Postoperatively, patient evaluated at discharge, 6 weeks, 3, 6, 12 and 24 months.
NuNec Cervical Disc: Patients will be enrolled and implanted with the NuNec device at a single level C3 to C7.</description>
          </group>
        </group_list>
        <measure>
          <title>Neck Disability Index (NDI) Score Improvement of at Least 15 Points</title>
          <description>The Neck Disability Index is a patient reported outcome measure for self-rated disability due to neck pain. Each of the 10 items is scored from 0 - 5. The maximum score is therefore 50. The obtained score can be multiplied by 2 to produce a percentage score. A higher score would indicate that the patient did not improve.</description>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="8"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="28.4" spread="27.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>&lt;0.05</p_value>
            <method>ANOVA</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Visual Analog Scale (VAS) Improvement of 2.0 cm for Neck Pain</title>
        <description>The pain Visual Analog Scale is a uni-dimensional measure of pain intensity, represented by a 100 mm line, anchored by &quot;no pain&quot; (score of 0) and &quot;pain as bad as it could be&quot; or &quot;worst imaginable pain&quot; (score of 100 [100-mm scale]). A higher score would indicate that the patient had a worse outcome.</description>
        <time_frame>At 24 months</time_frame>
        <group_list>
          <group group_id="O1">
            <title>NuNec Cervical Disc</title>
            <description>Each patient will be implanted with the NuNec Cervical Disc in a single level from C3 to C7. Postoperatively, patient evaluated at discharge, 6 weeks, 3, 6, 12 and 24 months.
NuNec Cervical Disc: Patients will be enrolled and implanted with the NuNec device at a single level C3 to C7.</description>
          </group>
        </group_list>
        <measure>
          <title>Visual Analog Scale (VAS) Improvement of 2.0 cm for Neck Pain</title>
          <description>The pain Visual Analog Scale is a uni-dimensional measure of pain intensity, represented by a 100 mm line, anchored by &quot;no pain&quot; (score of 0) and &quot;pain as bad as it could be&quot; or &quot;worst imaginable pain&quot; (score of 100 [100-mm scale]). A higher score would indicate that the patient had a worse outcome.</description>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="8"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.97" spread="3.27"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>&lt; 0.05</p_value>
            <method>ANOVA</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Serious Adverse Events Related to the Device</title>
        <description>The number of serious adverse events have been recorded</description>
        <time_frame>Up to 24 months</time_frame>
        <group_list>
          <group group_id="O1">
            <title>NuNec Cervical Disc</title>
            <description>Each patient will be implanted with the NuNec Cervical Disc in a single level from C3 to C7. Postoperatively, patient evaluated at discharge, 6 weeks, 3, 6, 12 and 24 months.
NuNec Cervical Disc: Patients will be enrolled and implanted with the NuNec device at a single level C3 to C7.</description>
          </group>
        </group_list>
        <measure>
          <title>Serious Adverse Events Related to the Device</title>
          <description>The number of serious adverse events have been recorded</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="8"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Device Failures or Removals, Revisions, Re-operations</title>
        <description>The failures or re-operations or supplemental fixation at the treated level</description>
        <time_frame>Up to 24 months</time_frame>
        <group_list>
          <group group_id="O1">
            <title>NuNec Cervical Disc</title>
            <description>Each patient will be implanted with the NuNec Cervical Disc in a single level from C3 to C7. Postoperatively, patient evaluated at discharge, 6 weeks, 3, 6, 12 and 24 months.
NuNec Cervical Disc: Patients will be enrolled and implanted with the NuNec device at a single level C3 to C7.</description>
          </group>
        </group_list>
        <measure>
          <title>Device Failures or Removals, Revisions, Re-operations</title>
          <description>The failures or re-operations or supplemental fixation at the treated level</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="8"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Patient Satisfaction</title>
        <description>As assessed on patient questionnaire.</description>
        <time_frame>At 24 months</time_frame>
        <group_list>
          <group group_id="O1">
            <title>NuNec Cervical Disc</title>
            <description>Each patient will be implanted with the NuNec Cervical Disc in a single level from C3 to C7. Postoperatively, patient evaluated at discharge, 6 weeks, 3, 6, 12 and 24 months.
NuNec Cervical Disc: Patients will be enrolled and implanted with the NuNec device at a single level C3 to C7.</description>
          </group>
        </group_list>
        <measure>
          <title>Patient Satisfaction</title>
          <description>As assessed on patient questionnaire.</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="8"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Very Satisfied</title>
                  <measurement_list>
                    <measurement group_id="O1" value="3"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Satisfied</title>
                  <measurement_list>
                    <measurement group_id="O1" value="4"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Somewhat Satisfied</title>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Unsatisfied</title>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Absence of Device Migration or Subsidence</title>
        <description>Absence of device migration &gt; 3mm; Absence of device subsidence &gt; 3mm</description>
        <time_frame>Up to 24 months</time_frame>
        <group_list>
          <group group_id="O1">
            <title>NuNec Cervical Disc</title>
            <description>Each patient will be implanted with the NuNec Cervical Disc in a single level from C3 to C7. Postoperatively, patient evaluated at discharge, 6 weeks, 3, 6, 12 and 24 months.
NuNec Cervical Disc: Patients will be enrolled and implanted with the NuNec device at a single level C3 to C7.</description>
          </group>
        </group_list>
        <measure>
          <title>Absence of Device Migration or Subsidence</title>
          <description>Absence of device migration &gt; 3mm; Absence of device subsidence &gt; 3mm</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="8"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>Adverse events were recorded over the 24 month follow-up period</time_frame>
      <group_list>
        <group group_id="E1">
          <title>NuNec Cervical Disc</title>
          <description>Each patient will be implanted with the NuNec Cervical Disc in a single level from C3 to C7. Postoperatively, patient evaluated at discharge, 6 weeks, 3, 6, 12 and 24 months.
NuNec Cervical Disc: Patients will be enrolled and implanted with the NuNec device at a single level C3 to C7.</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="14"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="14"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <default_assessment>Non-systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="14"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Musculoskeletal and connective tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Dysphagia</sub_title>
                <description>Ongoing Dysphagia (mainly to solids), hoarse voice ( improving)</description>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="14"/>
              </event>
              <event>
                <sub_title>Pain in L forearm</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="14"/>
              </event>
              <event>
                <sub_title>Hand Paranesthesia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="14"/>
              </event>
              <event>
                <sub_title>Hyperesthesia</sub_title>
                <description>Hyperesthesia C5/6 distribution L arm</description>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="14"/>
              </event>
              <event>
                <sub_title>Limited shoulder movement</sub_title>
                <description>Limited movement L shoulder</description>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="14"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Nervous system disorders</title>
            <event_list>
              <event>
                <sub_title>neurological impairment</sub_title>
                <description>1 patient developed a neurological impairment, this was not considered related to the surgery or the device.</description>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="14"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Robin Waite</name_or_title>
      <organization>RTI Surgical</organization>
      <phone>386-418-8888</phone>
      <email>rwaite@rtix.com</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

